Nationwide analysis of routine clinical practices in the management of acute ischemic stroke patients in China
Our findings showed relatively low utilization rates of thrombolytic (2.76%) and interventional therapies (3.23%) in China, highlighting the urgent need to improve access to these evidence-based reperfusion strategies. The use of neuroprotective agents, Chinese herbal medicine, acupuncture, and rehabilitation might be associated with reduced in-hospital mortality in AIS patients; however, future high-quality prospective studies are still warranted to confirm the clinical effects of these treatments.
Authors
- Xuan Qin (ORCID: https://orcid.org/0000-0001-5953-7812)
- Xiaochao Luo (ORCID: https://orcid.org/0000-0001-9595-5659)
- Yu Ma (ORCID: https://orcid.org/0000-0003-2175-3346)
- Minghong Yao (ORCID: https://orcid.org/0000-0001-8151-6014)
- Xin Sun (ORCID: https://orcid.org/0000-0002-6554-7088)
- Kang Zou (ORCID: https://orcid.org/0000-0002-4959-1951)
- Jiajie Yu (ORCID: https://orcid.org/0000-0003-4319-0820)
- Hao Li (ORCID: https://orcid.org/0000-0002-6499-4978)
- Jiali Liu (ORCID: https://orcid.org/0000-0002-2761-661X)
- Ling Li (ORCID: https://orcid.org/0000-0001-7689-1856)
- Yanmei Liu (ORCID: https://orcid.org/0000-0003-3071-906X)
- Fan Mei
- Hunong Xiang
- Jiayidaer Huan
Institutions
- Sichuan University (CN)
- West China Medical Center of Sichuan University (CN)
- Sichuan Research Center of New Materials (CN)
- Impact (CA)
- McMaster University (CA)
Publication Details
- Journal
- International Journal of Stroke
- Published
- 2025-06-19
- DOI
- https://doi.org/10.1177/17474930251344450
- Citations
- 1
- Primary Topic
- Acute Ischemic Stroke Management
- Type
- article
- Field-Weighted Citation Impact
- 1.35
Funders
- National Natural Science Foundation of China
- National Science Fund for Distinguished Young Scholars